Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens.
Bochtler T et al. J Clin Oncol. 2015 Mar 16. pii: JCO.2014.57.4947. [Epub ahead of print].
Extracorporeal Membrane Oxygenation as Bridge-to-Decision in Acute Heart Failure due to Systemic Light-Chain Amyloidosis.
Mancio Silva J et al. Am J Case Rep. 2015 Mar 24;15:174-81. doi: 10.12659/AJCR.892772.
Plasma cell leukemia: from biology to treatment.
Jelinek T et al. Eur J Haematol. 2015 Mar 16. doi: 10.1111/ejh.12533. [Epub ahead of print].
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
Kongtim P et al. Bone Marrow Transplant. 2015 Mar 2. doi: 10.1038/bmt.2015.21. [Epub ahead of print].